Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Front Immunol. 2023 Sep 25;14:1241600. doi: 10.3389/fimmu.2023.1241600. eCollection 2023.
Front Immunol. 2023.
PMID: 37818372
Free PMC article.
Clinical Trial.
Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Pavlovsky C, Vasconcelos Cordoba B, Sanchez MB, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, de Labanca AG, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Cueto G, Miranda S, Levy EM, Bianchini M.
Pavlovsky C, et al. Among authors: custidiano r.
J Hematol Oncol. 2023 Apr 29;16(1):43. doi: 10.1186/s13045-023-01440-6.
J Hematol Oncol. 2023.
PMID: 37120577
Free PMC article.
Item in Clipboard
[Clinical outcomes in cancer patients hospitalized with COVID-19].
Zylberman M, Díaz-Couselo FA, Irrazabal C, Flagel S, Custidiano R, Racciopi A, Nicolini C, Bachetti P, Rébora J, Manzano N, Tavella M, Valle S, Noro L, Halac S, Cassal E, Paganini L, Aguirre M, Dictar M.
Zylberman M, et al. Among authors: custidiano r.
Medicina (B Aires). 2021;81(5):695-702.
Medicina (B Aires). 2021.
PMID: 34633941
Free article.
Spanish.
Item in Clipboard
Cite
Cite